-
Regulatory, Safety & Market Access
-
Regulatory, Safety & Market Access
-
Peptide CMC & Process Development
-
Peptide CMC & Process Development
-
Regulatory, Safety & Market Access
-
Regulatory, Safety & Market Access
-
Regulatory, Safety & Market Access
-
Regulatory, Safety & Market Access
-
Innovation in Therapeutic Modalities
-
Innovation in Therapeutic Modalities
-
Translational & Clinical Strategy
-
Translational & Clinical Strategy
-
Innovation in Therapeutic Modalities
-
Innovation in Therapeutic Modalities
-
Peptide CMC & Process Development
-
Peptide CMC & Process Development
-
Peptide CMC & Process Development
-
Peptide CMC & Process Development
-
Translational & Clinical Strategy
-
Translational & Clinical Strategy
-
Oligonucleotide CMC & Process Development
-
Oligonucleotide CMC & Process Development
-
Regulatory, Safety & Market Access
-
Regulatory, Safety & Market Access
-
-
Innovation in Therapeutic Modalities
-
Translational & Clinical Strategy
-
Oligonucleotide CMC & Process Development
-
Peptide CMC & Process Development
-
Regulatory, Safety & Market Access
Afternoon Refreshments
-
-
Innovation in Therapeutic Modalities
-
Translational & Clinical Strategy
-
Oligonucleotide CMC & Process Development
-
Peptide CMC & Process Development
-
Regulatory, Safety & Market Access
-
-
Innovation in Therapeutic Modalities
-
Translational & Clinical Strategy
-
Oligonucleotide CMC & Process Development
-
Peptide CMC & Process Development
-
Regulatory, Safety & Market Access
Evening Drinks Reception
-
Oligonucleotide CMC & Process Development
-
Oligonucleotide CMC & Process Development
-
Innovation in Therapeutic Modalities
-
Innovation in Therapeutic Modalities
-
-
Innovation in Therapeutic Modalities
-
Translational & Clinical Strategy
-
Oligonucleotide CMC & Process Development
-
Peptide CMC & Process Development
-
Regulatory, Safety & Market Access
-
-
Innovation in Therapeutic Modalities
-
Translational & Clinical Strategy
-
Oligonucleotide CMC & Process Development
-
Peptide CMC & Process Development
-
Regulatory, Safety & Market Access
1-2-1 Meetings/Networking Break
-
-
Innovation in Therapeutic Modalities
-
Translational & Clinical Strategy
-
Oligonucleotide CMC & Process Development
-
Peptide CMC & Process Development
-
Regulatory, Safety & Market Access
1-2-1 Meetings/Networking Break
-
-
Innovation in Therapeutic Modalities
-
Translational & Clinical Strategy
-
Oligonucleotide CMC & Process Development
-
Peptide CMC & Process Development
-
Regulatory, Safety & Market Access
Networking Lunch
-
Translational & Clinical Strategy
-
Translational & Clinical Strategy
-
Oligonucleotide CMC & Process Development
-
Oligonucleotide CMC & Process Development
-
-
Innovation in Therapeutic Modalities
-
Translational & Clinical Strategy
-
Oligonucleotide CMC & Process Development
-
Peptide CMC & Process Development
-
Regulatory, Safety & Market Access
Morning Refreshments
-
-
Innovation in Therapeutic Modalities
-
Translational & Clinical Strategy
-
Oligonucleotide CMC & Process Development
-
Peptide CMC & Process Development
-
Regulatory, Safety & Market Access
1-2-1 Meetings/Networking Break
-
-
Innovation in Therapeutic Modalities
-
Translational & Clinical Strategy
-
Oligonucleotide CMC & Process Development
-
Peptide CMC & Process Development
-
Regulatory, Safety & Market Access
1-2-1 Meetings/Networking Break
-
Peptide CMC & Process Development
-
Peptide CMC & Process Development
-
-
Innovation in Therapeutic Modalities
-
Translational & Clinical Strategy
-
Oligonucleotide CMC & Process Development
-
Peptide CMC & Process Development
-
Regulatory, Safety & Market Access
Registration
-
Translational & Clinical Strategy
-
Translational & Clinical Strategy
-
Innovation in Therapeutic Modalities
-
Innovation in Therapeutic Modalities
Circular DNA exists as an endogenous molecule in human cells with emerging relevance to health and d
...
-
Oligonucleotide CMC & Process Development
-
Oligonucleotide CMC & Process Development
Manufacturing of long RNA oligos: Synthesis and analytical strategies and challenges Scaling Up Oli
...